Debiopharm is an independent biopharmaceutical company based in Switzerland with an ongoing commitment to improve patient outcomes and quality of life in oncology and bacterial infections. Our main activities include drug development, drug manufacturing and digital health investment. Debiopharm’s vision of healthcare is not limited to making new medicines available. We strongly believe you can be an actor in your own medical care.
Through corporate responsibility we aim to positively contribute to society and the environment by taking care of the planet and the people we share it with.
- Improving patient quality of life through continuous innovation
- Taking care of our people by providing a rewarding workplace
- Being a trustworthy partner
- Minimizing the negative impact of our actions on the planet
- Actively engaging in the communities we work in and with
We believe that all forms of diversity are a?valuable source of creativity and innovation.? Promoting equality in the workplace?is?part of?our DNA and supported by longstanding policies to manage pay rigorously.
Our equal?pay analysis was carried out with the support of Willis Towers Watson in our Lausanne headquarters and with CEPEC in our Martigny production site,?world leading experts in compensation.
The analysis and the results?were then?validated by an independent auditor?in compliance?with the Swiss Law.?As a result?of fully living our?values, we?are extremely proud to report that we pay men and women equally for equal work! In other words, we do not have a pay equity gap between men and women.